Docoh
Loading...

CDMO Avid Bioservices

Avid Bioservices, Inc. engages in the commercial manufacturing which focuses on biopharmaceutical products derived from mammalian cell culture for culture for biotechnology and pharmaceutical companies. The firm specializes in clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory submissions, and support. The company was founded on June 3, 1981 and is headquartered in Tustin, CA.

Company profile

Ticker
CDMO, CDMOP
Exchange
Website
CEO
Nicholas Green
Employees
Incorporated
Location
Fiscal year end
Former names
PEREGRINE PHARMACEUTICALS INC, TECHNICLONE CORP/DE/, TECHNICLONE INTERNATIONAL CORP
SEC CIK
IRS number
953698422

CDMO stock data

(
)

Calendar

8 Mar 21
21 Apr 21
30 Apr 21
Quarter (USD)
Jan 21 Oct 20 Jul 20 Apr 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Apr 20 Apr 19 Apr 18 Apr 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
12 Apr 21 Ziebell Mark R 10.5% Series E Convertible Preferred Stock Common Stock Other Dispose J No No 25.08 900 22.57K 0
17 Mar 21 Bamforth Mark R Common Stock, $0.001 par value Buy Aquire P Yes No 18.18 126,000 2.29M 126,000
17 Mar 21 Bamforth Mark R Common Stock, $0.001 par value Sell Dispose S Yes No 18.18 26,000 472.68K 0
17 Mar 21 Bamforth Mark R Common Stock, $0.001 par value Sell Dispose S No No 18.18 100,000 1.82M 0
31 Dec 20 Hart Daniel Ryan Common Stock Other Aquire J No No 6.0563 1,754 10.62K 19,737
14 Dec 20 Carleone Joseph RSU Common Stock Grant Aquire A No No 0 2,379 0 2,379
14 Dec 20 Carleone Joseph Stock Option Common Stock Grant Aquire A No No 10.72 10,030 107.52K 124,305
14 Dec 20 Bamforth Mark R RSU Common Stock Grant Aquire A No No 0 2,379 0 2,379
14 Dec 20 Bamforth Mark R Stock Option Common Stock Grant Aquire A No No 10.72 10,030 107.52K 124,305

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

13F holders
Current Prev Q Change
Total holders 0 0
Opened positions 0 0
Closed positions 0 0
Increased positions 0 0
Reduced positions 0 0
13F shares
Current Prev Q Change
Total value 0 0
Total shares 0 0
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
Largest transactions
Shares Bought/sold Change

Financial report summary

?
Management Discussion
  • Revenues for the three months ended January 31, 2021 and 2020 were $21.8 million and $13.6 million, respectively, an increase of $8.2 million or 61%. The increase in revenues can be attributed to a $6.4 million increase in manufacturing revenues primarily due to an increase in the number and scope of manufacturing runs in-process and/or completed in the current year period compared to the prior year period, combined with a $1.8 million increase in process development revenues. The increase in revenues was attributed to the following components of our revenue streams:
  • Additionally, as previously disclosed, prior-year period manufacturing revenue was impacted by a production interruption.
  • Gross profit for the three months ended January 31, 2021 and 2020 was $6.2 million and $0.8 million, respectively, an increase of approximately $5.4 million, and gross margins for such periods were 28% and 6%, respectively. The increase in gross profit for the current-year period can primarily be attributed to increased revenues, partially offset by an increase in payroll related costs. In addition, the prior-year period gross profit was impacted by certain costs associated with the production interruption described above, which costs were not incurred during the current-year period.
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. junior Avg
New words: Chairman, deducting, double, guarantee, high, member, notified, Patrick, prioritized, purported, pursue, resign, resignation, short, squeeze, underwriting, underwritten, undiscounted, Walsh
Removed: exist